Evidence map›Paper›PMID 31855533›Full record

ArticleEmerging infectious diseases2020

Antigenic Variant of Highly Pathogenic Avian Influenza A(H7N9) Virus, China, 2019.

Wenming Jiang, Guangyu Hou, Jinping Li, Cheng Peng, Suchun Wang, Shuo Liu, Qingye Zhuang, Liping Yuan, Xiaohui Yu, Yang Li and 2 more

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Avian influenza overview May - August 2020.EFSA journal. European Food Safety Authority · 2020
    Article
  9. Article
  10. Avian influenza overview February - May 2020.EFSA journal. European Food Safety Authority · 2020
    Article
  11. Avian influenza overview November 2019- February2020.EFSA journal. European Food Safety Authority · 2020
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Wenming Jiang
Guangyu Hou
Jinping Li
Cheng Peng
Suchun Wang
Shuo Liu
Qingye Zhuang
Liping Yuan
Xiaohui Yu
Yang Li
Jingjing Wang
Hualei Liu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In China, influenza A(H7N9) virus appeared in 2013, then mutated into a highly pathogenic virus, causing outbreaks among poultry and cases in humans. Since September 2017, extensive use of the corresponding vaccine, H7-Re1, successfully reduced virus prevalence. However, in 2019, a novel antigenic variant emerged, posing considerable economic and public health threats.A.

Indexed as

antigenicityChinaH7N9highly pathogenic avian influenzaHPAIinfluenzaInfluenza virusvariantviruses

Identifiers

PMID31855533
PMCPMC6986829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.